Strong Q3 2025 led by Registry Operations and resilient, diversified, Services segment; diluted EPS $0.45Company currently on track to hit net leverage target range of 2.0x - 2.5x by 2026Guidance for ...

NEW YORK CITY, NEW YORK / ACCESS Newswire / November 4, 2025 / Business owners usually know when they've outgrown their basic business accounts. But figuring out what comes next isn't always as ...

Topicus.com Inc. (TSXV:TOI) in a joint release with Constellation Software Inc. (TSX:CSU) today announced financial results for Topicus.com Inc. ('Topicus” or the 'Company”) for the third quarter ...

Year Over Year CAVA Revenue Growth of 20.0% Including CAVA Same Restaurant Sales Growth of 1.9% Third Quarter 2025 CAVA Restaurant-Level Profit Margin of 24.6% WASHINGTON-- (BUSINESS WIRE)--November ...

Mix of institutional buyers -- Institutional buyer contracts made up 4.6% of backlog (60 homes) at quarter-end, down from ...

Third quarter 2025 net revenue was $118.8 million, up slightly compared to $118.6 million in the third quarter of 2024, fueled by the timing of Rejuvenate 2.0 shipments and the continued expansion of ...

RECAP as Chancellor Rachel Reeves uses an early morning speech in Downing Street to address 'speculation' about the contents ...

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced financial results for the third quarter ended September 30, 2025.